Marcelo A. Nobrega to Genome-Wide Association Study
This is a "connection" page, showing publications Marcelo A. Nobrega has written about Genome-Wide Association Study.
Connection Strength
0.620
-
Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women. Alzheimers Dement. 2023 03; 19(3):896-908.
Score: 0.118
-
Identification of atrial fibrillation associated genes and functional non-coding variants. Nat Commun. 2019 10 18; 10(1):4755.
Score: 0.098
-
A promoter interaction map for cardiovascular disease genetics. Elife. 2018 07 10; 7.
Score: 0.090
-
In vitro scan for enhancers at the TCF7L2 locus. Diabetologia. 2013 Jan; 56(1):121-5.
Score: 0.060
-
An in vivo cis-regulatory screen at the type 2 diabetes associated TCF7L2 locus identifies multiple tissue-specific enhancers. PLoS One. 2012; 7(5):e36501.
Score: 0.058
-
Transcriptional enhancers in development and disease. Genome Biol. 2012 Jan 23; 13(1):238.
Score: 0.057
-
An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res. 2010 Sep; 20(9):1191-7.
Score: 0.052
-
African-specific alleles modify risk for asthma at the 17q12-q21 locus in African Americans. Genome Med. 2022 09 29; 14(1):112.
Score: 0.030
-
Altered Enhancer and Promoter Usage Leads to Differential Gene Expression in the Normal and Failed Human Heart. Circ Heart Fail. 2020 10; 13(10):e006926.
Score: 0.026
-
TCF7L2 is a master regulator of insulin production and processing. Hum Mol Genet. 2014 Dec 15; 23(24):6419-31.
Score: 0.017
-
The emerging genetic landscape underlying cardiac conduction system function. Birth Defects Res A Clin Mol Teratol. 2011 Jun; 91(6):578-85.
Score: 0.014